47. Gross TL, Ihrke PE, Walder EJ, et al. Pustular diseases of the epidermis. Skin diseases of the dog and cat. 2nd ed. Ames, Iowa: Blackwell, 2005;3-26.
48. Graham-Mize CA, Rosser EJ. Bioavailability and activity of prednisone and prednisolone in the feline patient (abstr).
Vet Dermatol 2004;15:10.
49. Olivry T, Murphy KM, Bizikova P. Immunosuppression of canine pemphigus foliaceus with traditional vs. pulse oral glucocorticoid
protocols: preliminary comparisons of treatment outcome (abstr). Vet Dermatol 2008;19:51.
50. White SD, Stewart LJ, Bernstein M. Corticosteroid (methylprednisolone sodium succinate) pulse therapy in five dogs with
autoimmune skin disease. J Am Vet Med Assoc 1987;191(9):1121-1124.
51. Gomez SM, Morris DO, Rosenbaum MR, et al. Outcome and complications associated with treatment of pemphigus foliaceus in
dogs: 43 cases (1994-2000). J Am Vet Med Assoc 2004;224(8):1312-1316.
52. Rosenkrantz WS. Pemphigus: current therapy. Vet Dermatol 2004;15(2):90-98.
53. Kidd LB, Salavaggione OE, Szumlanski CL, et al. Thiopurine methyltransferase activity in red blood cells of dogs. J Vet Intern Med 2004;18(2):214-218.
54. White SD, Rosychuk RA, Outerbridge CA, et al. Thiopurine methyltransferase in red blood cells of dogs, cats, and horses.
J Vet Intern Med 2000;14(5):499-502.
55. Matsuda S, Koyasu S. Mechanism of action of cyclosporine. Immunopharmacology 2000;47(2-3):119-125.
56. Robson D. Review of the properties and mechanisms of action of cyclosporine with an emphasis on dermatological therapy
in dogs, cats and people. Vet Rec 2003;152(25):768-772.
57. Robson D. Review of the pharmacokinetics, interactions and adverse reactions of cyclosporine in people, dogs and cats.
Vet Rec 2003;152(24):739-748.
58. Werner AH. Psoriasiform-lichenoid-like dermatosis in three dogs treated with microemulsified cyclosporine A. J Am Vet Med Assoc 2003;223(7):1013-1016.
59. Barrs VR, Martin P, Beatty JA. Antemortem diagnosis and treatment of toxoplasmosis in two cats on cyclosporine therapy.
Aust Vet J 2006;84(1-2):30-35.
60. Olivry T, Rivierre C, Murphy KM. Efficacy of cyclosporine for treatment induction of canine pemphigus foliaceus. Vet Rec 2003;152(2):53-54.
61. Rosenkrantz WS, Aniya JS. Cyclosporine, ketoconazole and azathioprine combination therapy in three cases of refractory
canine pemphigus foliaceus (abstr). Vet Dermatol 2007;18:192.
62. Maeda H, Takahashi M, Nakashima K, et al. Treatment of five dogs with pemphigus foliaceus with cyclosporine and prednisone
(abstr). Vet Dermatol 2008;19:51.
63. Bensignor E, Olivry T. Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded
randomized controlled trial. Vet Dermatol 2005;16(1):52-60.
64. Griffies JD, Mendelsohn CL, Rosenkrantz WS, et al. Topical 0.1% tacrolimus for the treatment of discoid lupus erythematosus
and pemphigus erythematosus in dogs. J Am Anim Hosp Assoc 2004;40(1):29-41.
65. Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 2006;54(2):258-265.
66. White SD, Rosychuk RA, Reinke SI, et al. Use of tetracycline and niacinamide for treatment of autoimmune skin disease
in 31 dogs. J Am Vet Med Assoc 1992;200(10):1497-1500.
67. Olivry T, Bergvall KE, Atlee B. Prolonged remission after immunosuppressive therapy in six dogs with pemphigus. Vet Dermatol 2004;15(4):245-252.
|
Featuring Information from:
